Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis.

摘要

Current guidelines for the treatment of deep vein thrombosis (DVT) recommend initial treatment with low molecular weight heparin (LMWH) or unfractionated heparin (UFH), followed by treatment with vitamin K antagonist (VKA) for at least 3 months [1]. Additional treatment with catheter-directed thrombolysis (CDT) is recommended in selected patients with extensive proximal DVT, to prevent post-thrombotic syndrome (PTS) [1].